| Literature DB >> 15569020 |
Lucy K Martin1, Paolo Romanelli, Yeon Soong Ahn, Robert S Kirsner.
Abstract
Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors presented with TMEP. TMEP is often refractory to therapy; however, our patient responded to treatment with PUVA.Entities:
Mesh：
Year: 2004 PMID： 15569020 DOI： 10.1111/j.1365-4632.2004.02249.x
Source DB: PubMed Journal: Int J Dermatol ISSN： 0011-9059 Impact factor: 2.736